ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 4,990.00
-530.00 (-9.60%)
At close: Apr 2, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 103.73 billion as of April 2, 2026. Its market cap has increased by 88.60% in one year.
Market Cap
103.73B
Enterprise Value
66.43B
Revenue
278.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,990.00
Market Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 103.73B, a decrease of -81.52%. That is a compound annual growth rate of -30.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 102.29B | -48.82% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | 561.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 121.35B |
| BIO-FD&C | 120.70B |
| KoBioLabs | 115.54B |
| CORESTEMCHEMON | 112.23B |
| Quratis | 102.92B |
| TegoScience | 102.32B |
| CHA Vaccine Research Institute | 100.34B |
| Cell Biotech | 98.55B |